HNC: pre-CRT lymphocyte-to-monocyte ratio predicts survival
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
The pretreatment lymphocyte-to-monocyte ratio (LMR) is an independent prognostic factor for patients with head and neck cancer (HNC) undergoing chemoradiotherapy (CRT).
A high LMR was associated with laryngeal cancer (P=.049), T1-T2 stage disease (P=.038), and clinical stage I-II disease (P=.046).
A high neutrophil-to-lymphocyte ratio (NLR) was associated with oropharyngeal/hypopharyngeal cancer (P=.004), T3-T4 stage disease (P=.005), N2b-N3 stage disease (P<.001), and clinical stage III-IV disease (P=.003).
High NLR, high platelet-to-lymphocyte ratio (PLR), and low LMR were associated with reduced OS (P<.0001, P=.001, and P<.0001, respectively) and DFS (P<.0001, P=.006, and P<.0001, respectively).
LMR was independently associated with prognosis in multivariate analysis (HR, 0.439; 95% CI, 0.282-0.685; P<.001).
285 patients with HNC treated with CRT were analyze...